Registrar in Clinical Oncology

Job summary

We are looking to appoint enthusiastic and forward-thinking doctors to the post of Registrar in Clinical Oncology. This post is offered on a fixed-term basis until 2nd March 2027 to cover a gap in the current Deanery rotation. There may be scope to extend the appointment for a further six months, subject to confirmation of Deanery placements and continued service requirements.

To fulfil the responsibilities of the post, the successful candidate will be required to demonstrate experience in oncological management and preferably hold MRCP or an equivalent qualification. The post may also be attractive to candidates preparing for the FRCR.

Main duties of the job

The post would be particularly suitable for experienced international oncologists wishing to gain further specialist experience in an international tertiary centre. The post could also be tailored to an experienced medical doctor who having completed Foundation and Core Medical competencies (or equivalent), wish to gain a period of focused experience and training in Clinical Oncology before pursuing ST3 training.

The specialty of Clinical Oncology comprises management of cancer using both radiotherapy and systemic therapy (chemotherapy, hormone therapy and biological agents). It offers a unique opportunity to develop expertise in managing cancer patients and engaging in clinical research and academia. A multidisciplinary team approach and effective communication is integral to the specialty of oncology.

About us

The Royal Marsden is a world leader in cancer research, treatment and education. Together with our academic partner, The Institute of Cancer Research (ICR), we are the largest comprehensive cancer centre in Europe and the only National Institute of Health Research (NIHR) Biomedical Research Centre specialising in cancer in the UK.

Our mission is to continue to make a national and international contribution to cancer research and treatment, so that more people are cured and quality of life is improved for those with cancer. The Royal Marsden therefore plays an important role in championing change and improvement in cancer care through research and innovation, education and leading-edge treatment.

We have a reputation for delivering high quality performance. We were ranked joint first in the CQC national inpatient survey results, above average in national cancer patient experience survey and ranked first amongst teaching hospitals in the UK for our staff survey results.

Predominantly the Trust's workload is from within the South West and West London Cancer Networks but, as a specialist cancer, the Trust has a high out-of-area referral rate for rare cancers, recurrent disease and treatment-related problems including international referrals. The Trust operates a shared care model with St George's Healthcare NHS Trust for paediatric cancer.